4-butyrolactone has been researched along with Condition, Preneoplastic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amano, Y; Fukuhara, H; Ishihara, S; Ishimura, N; Kinoshita, Y; Mishima, Y; Sanchez-Siles, AA; Takahashi, Y; Tamagawa, Y; Uno, G; Yuki, T | 1 |
| Hara, A; Makita, H; Mori, H; Ohnishi, M; Satoh, K; Tamai, Y; Tanaka, T; Torihara, M; Yamahara, J | 1 |
| Kawamori, T; Mori, H; Okamoto, K; Suzui, M; Tamai, Y; Tanaka, T; Torihara, M; Yamahara, J | 1 |
| Ball, HW; Manson, MM; McLellan, LI; Shepherd, AG | 1 |
4 other study(ies) available for 4-butyrolactone and Condition, Preneoplastic
| Article | Year |
|---|---|
Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
Topics: 4-Butyrolactone; Adenocarcinoma; Aged; Antigens, CD34; Apoptosis; Barrett Esophagus; Bile Acids and Salts; Biopsy; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Chi-Square Distribution; Cyclooxygenase 2; Disease Progression; Enzyme Inhibitors; Esophageal Neoplasms; Esophagoscopy; Fatty Acid Synthase, Type I; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Hydrogen-Ion Concentration; Immunohistochemistry; Japan; Logistic Models; Male; Middle Aged; Odds Ratio; Precancerous Conditions; Proliferating Cell Nuclear Antigen; Risk Assessment; Risk Factors; RNA, Messenger; Time Factors | 2011 |
Inhibition of 4-nitroquinoline-1-oxide-induced rat oral carcinogenesis by dietary exposure of a new retinoidal butenolide, KYN-54, during the initiation and post-initiation phases.
Topics: 4-Butyrolactone; 4-Nitroquinoline-1-oxide; Animals; Anticarcinogenic Agents; Biogenic Polyamines; Bromodeoxyuridine; Carcinogens; Cell Division; Male; Mouth Neoplasms; Nuclear Proteins; Nucleolus Organizer Region; Precancerous Conditions; Rats; Rats, Inbred F344; Retinoids; Silver Staining | 1995 |
Chemoprevention of azoxymethane-induced intestinal carcinogenesis by a novel synthesized retinoidal butenolide, 5-hydroxy-4-(2-phenyl-(E)-ethenyl)-2(5H)-furanone, in rats.
Topics: 4-Butyrolactone; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Azoxymethane; Biomarkers, Tumor; Bromodeoxyuridine; Colon; Dose-Response Relationship, Drug; Epithelium; Intestinal Neoplasms; Male; Ornithine Decarboxylase; Precancerous Conditions; Rats; Rats, Inbred F344; Retinoids | 1995 |
Regulation of rat glutamate-cysteine ligase (gamma-glutamylcysteine synthetase) subunits by chemopreventive agents and in aflatoxin B(1)-induced preneoplasia.
Topics: 4-Butyrolactone; Aflatoxin B1; Animals; Anticarcinogenic Agents; Antioxidants; Carcinogens; Catalytic Domain; Coumarins; Diet; Ellagic Acid; Enzyme Induction; Ethoxyquin; Glutamate-Cysteine Ligase; Glutathione; Inactivation, Metabolic; Liver; Liver Neoplasms, Experimental; Male; Phenobarbital; Precancerous Conditions; Rats; Rats, Inbred F344; Rats, Wistar | 2000 |